Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann  1     Alfredo J. Lucendo  2     Stephan Miehlke  3     Michael Vieth  4     Christoph Schlag  5     Luc Biedermann  6     Cecilio Santander Vaquero     Constanza Ciriza De Los Ríos     Dirk Hartmann     Ahmed Madisch     Petr Hruz     Jamal Hayat     Ulrike von Arnim     Arjan Bredenoord     Stefan Schubert     Ralph Müller     Roland Greinwald     Alain Schoepfer     Stephen     
1 Swiss EoE Research Network,Olten,Switzerland
2 Hospital General de Tomelloso Dept. of Digestive Health,Tomelloso,Spain
3 Coopertion of Internal Medicine Center for Digestive Diseases,Hamburg,Germany
4 Klinikum Bayreuth Abt. Pathology,Bayreuth,Germany
5 Technische Universität München,München,Germany
6 USZ Z&uu

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing